FDA Says No More Compounded Weight Loss Drugs – Industry OFA Appeal Shot Down
March 14, 2025 On Mar. 5, a judge denied a request from the Outsourcing Facilities Association (OFA), an industry group for compounding pharmacies, to block the FDA’s attempt to stop the production of compounded tirzepatide. Generally, making copies of brand-name drugs is not legal until their patents expire. But there are exceptions: Compounding pharmacies can […]
FDA Says No More Compounded Weight Loss Drugs – Industry OFA Appeal Shot Down Read More »